Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Rimner

Showing results (191-200 of 272) with videos related to

Pageof 28
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 10, 2026
Challenges and Controversies in the Diagnosis and Management of Thymic Epithelial Tumors from the Thymic Tumor Subcommittee of the International Association for the Study of Lung Cancer Rare Tumors CommitteeFatemeh Ardeshir-Larinani, Leanne Ashrafian, Marco Chiappetta, et al.
Acta Oncologica (Stockholm, Sweden)|June 7, 2018
Stereotactic body radiation therapy (SBRT) improves local control and overall survival compared to conventionally fractionated radiation for stage I non-small cell lung cancer (NSCLC)Donata von Reibnitz, Fauzia Shaikh, Abraham J Wu, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 14, 2024
An <sup>18</sup>F-FDG PET/CT and Mean Lung Dose Model to Predict Early Radiation Pneumonitis in Stage III Non-Small Cell Lung Cancer Patients Treated with Chemoradiation and ImmunotherapyMaria Thor, Chen Lee, Lian Sun, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 13, 2024
Biomarkers associated with pulmonary exacerbations in a randomized trial of nintedanib for radiation pneumonitisZachary R Moore, Xiaojing Huang, Stephanie Lobaugh, et al.
Clinical and Translational Radiation Oncology|April 9, 2026
Outcome and safety of SBRT in centrally and ultra-centrally located lung tumours: A PRISMA-based systematic review and Meta-AnalysisShari Wiegreffe, Sonja Adebahr, Tanja Schimek-Jasch, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 12, 2024
Ongoing prospective studies on reirradiation: A systematic review of a clinical trials databaseJonas Willmann, Panagiotis Balermpas, Andreas Rimner, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 11, 2024
Response letter to "Stereotactic body radiation therapy for pleural mesothelioma: Which goal, which patients"Jacob Y Shin, Michael Offin, Charles B Simone, et al.
Cancer Medicine|May 7, 2020
Radiation pneumonitis in lung cancer patients treated with chemoradiation plus durvalumabNarek Shaverdian, Maria Thor, Annemarie F Shepherd, et al.
JAMA Oncology|April 11, 2024
American Radium Society Appropriate Use Criteria for Unresectable Locally Advanced Non-Small Cell Lung CancerGeorge Rodrigues, Kristin A Higgins, Andreas Rimner, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 4, 2020
Clinical outcomes, local-regional control and the role for metastasis-directed therapies in stage III non-small cell lung cancers treated with chemoradiation and durvalumabMichael Offin, Narek Shaverdian, Andreas Rimner, et al.
Pageof 28

Showing results (191-200 of 272) with videos related to

Sort By:
Pageof 28
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 10, 2026
Challenges and Controversies in the Diagnosis and Management of Thymic Epithelial Tumors from the Thymic Tumor Subcommittee of the International Association for the Study of Lung Cancer Rare Tumors CommitteeFatemeh Ardeshir-Larinani, Leanne Ashrafian, Marco Chiappetta, et al.
Acta Oncologica (Stockholm, Sweden)|June 7, 2018
Stereotactic body radiation therapy (SBRT) improves local control and overall survival compared to conventionally fractionated radiation for stage I non-small cell lung cancer (NSCLC)Donata von Reibnitz, Fauzia Shaikh, Abraham J Wu, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 14, 2024
An <sup>18</sup>F-FDG PET/CT and Mean Lung Dose Model to Predict Early Radiation Pneumonitis in Stage III Non-Small Cell Lung Cancer Patients Treated with Chemoradiation and ImmunotherapyMaria Thor, Chen Lee, Lian Sun, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 13, 2024
Biomarkers associated with pulmonary exacerbations in a randomized trial of nintedanib for radiation pneumonitisZachary R Moore, Xiaojing Huang, Stephanie Lobaugh, et al.
Clinical and Translational Radiation Oncology|April 9, 2026
Outcome and safety of SBRT in centrally and ultra-centrally located lung tumours: A PRISMA-based systematic review and Meta-AnalysisShari Wiegreffe, Sonja Adebahr, Tanja Schimek-Jasch, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 12, 2024
Ongoing prospective studies on reirradiation: A systematic review of a clinical trials databaseJonas Willmann, Panagiotis Balermpas, Andreas Rimner, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 11, 2024
Response letter to "Stereotactic body radiation therapy for pleural mesothelioma: Which goal, which patients"Jacob Y Shin, Michael Offin, Charles B Simone, et al.
Cancer Medicine|May 7, 2020
Radiation pneumonitis in lung cancer patients treated with chemoradiation plus durvalumabNarek Shaverdian, Maria Thor, Annemarie F Shepherd, et al.
JAMA Oncology|April 11, 2024
American Radium Society Appropriate Use Criteria for Unresectable Locally Advanced Non-Small Cell Lung CancerGeorge Rodrigues, Kristin A Higgins, Andreas Rimner, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 4, 2020
Clinical outcomes, local-regional control and the role for metastasis-directed therapies in stage III non-small cell lung cancers treated with chemoradiation and durvalumabMichael Offin, Narek Shaverdian, Andreas Rimner, et al.
Pageof 28